Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Spex Capital is a venture capital firm founded by Claudio D’Angelo, based in England and Wales. The firm manages a €100 million fund and is authorized by the Financial Conduct Authority. Spex Capital focuses on early-stage investments in the digital technology sector, particularly healthcare.
Spex Capital specializes in early-stage investments in digital healthcare and med-tech startups. The firm typically invests between €500,000 to €2 million at the seed stage and up to €5 million at Series A. They also consider follow-on investments in Series B for companies they know well.
Spex Capital has a portfolio of seven companies, with a total investment of €29 million and a current valuation exceeding €190 million. Their investments reflect a multidisciplinary approach, drawing on the team's expertise in finance, digital technology, and medicine.
Email team@spexcapital.com with your deck to pitch Spex Capital.
Yes, Spex Capital often leads investment rounds, particularly in seed and Series A stages.
Spex Capital is open to follow-on investments in Series B for companies they are familiar with, ensuring continued support for their portfolio.
The firm manages a €100 million fund, specifically targeting early-stage digital healthcare ventures.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.